Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNYR
SNYR logo

SNYR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.195
Open
1.160
VWAP
1.18
Vol
8.93K
Mkt Cap
13.16M
Low
1.160
Amount
10.50K
EV/EBITDA(TTM)
5.80
Total Shares
11.25M
EV
36.81M
EV/OCF(TTM)
--
P/S(TTM)
0.29
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Show More

Events Timeline

(ET)
2026-01-27
08:10:00
Synergy CHC Expands FOCUSfactor Product Line in Canada
select
2025-12-16 (ET)
2025-12-16
08:10:00
Synergy CHC Appoints Pedro Colmenares as Sales & Marketing Director for Mexico & Latin America
select
2025-12-15 (ET)
2025-12-15
08:10:00
Synergy CHC Announces New Partnerships with Beverage Companies
select
2025-11-18 (ET)
2025-11-18
09:30:20
Synergy CHC Welcomes Five New Direct Store Delivery Partners
select
2025-11-13 (ET)
2025-11-13
08:12:41
Synergy CHC Announces Q3 Earnings Per Share of 1 Cent Compared to 11 Cents Last Year
select
2025-11-05 (ET)
2025-11-05
08:15:20
Synergy CHC Forms Strategic Distribution Alliance with C&M Sales
select
2025-10-22 (ET)
2025-10-22
08:08:52
Synergy CHC Reveals New Retail Authorizations and Distribution Collaboration
select
2025-10-20 (ET)
2025-10-20
08:16:37
Synergy CHC Forms Distribution Alliance with Atlantic Importing
select

News

Yahoo Finance
1.0
02-21Yahoo Finance
New Show to Air Tonight on Bloomberg Television
  • Global Broadcast Expansion: New to The Street's latest episode will air tonight at 6:30 PM EST on Bloomberg Television, extending its reach to the U.S., MENA, and Latin America, thereby enhancing international investor engagement and broadening its audience base.
  • Biotech Advancements: BioVie Inc. is advancing a clinical trial for Parkinson's disease with 60 patients enrolled, expecting topline data in May 2026, which could significantly bolster its market position in the biopharmaceutical sector if successful.
  • Obstructive Sleep Apnea Solutions: Vivos Therapeutics Inc.'s FDA-cleared non-surgical oral appliance aims to provide a long-term solution for the estimated one billion people affected by OSA globally, with strategic growth initiatives targeting direct-to-patient markets.
  • Virtual Reality Market Growth: Virtuix Holdings Inc.'s Omni One platform has reported a 138% year-over-year growth in the gaming and fitness sectors, with production capacity supporting potential annual revenues of up to $100 million, indicating strong demand in both consumer and defense markets.
Yahoo Finance
8.5
02-07Yahoo Finance
New Show Airing on Bloomberg Television
  • Rich Program Content: Tonight's airing of 'New to The Street' on Bloomberg Television will showcase Virtuix's immersive technology platform, highlighting its rapid growth in consumer and defense markets, which is expected to attract a wide audience.
  • International Expansion Update: YY Group will provide updates on its international expansion in Hong Kong, UAE, and Southeast Asia, showcasing AI-enabled workforce automation and strong revenue momentum, indicating its competitiveness in the premium client market.
  • Strategic Acquisition Discussion: Roadzen's leadership will discuss its strategic acquisition plans and the scaling of its AI-driven auto insurance and claims ecosystem, demonstrating its innovative capabilities and market potential in the insurance industry.
  • Fintech Strategy: Alphaton Capital will outline its fintech-driven investment strategy and capital markets positioning in an interview filmed at the New York Stock Exchange, enhancing its credibility and appeal among global investors.
Yahoo Finance
1.0
01-17Yahoo Finance
New to The Street Broadcasts Show #716 Featuring SDST and Others
  • Broadcast Timing: New to The Street will air Show #716 tonight at 6:30 PM Eastern Time on Bloomberg Television, enhancing its influence in the business media landscape by showcasing various public companies.
  • Company Highlights: The episode will spotlight Stardust Power Inc. (NASDAQ:SDST), BioVie Inc. (NASDAQ:BIVI), and Roadzen Inc. (NASDAQ:RDZN), showcasing innovations in critical minerals, biotechnology, and AI-driven mobility and insurance solutions, aimed at attracting investor interest.
  • Celebrity Features: The show will also include special segments with Kelsey Grammer discussing his new book KAREN and Andrew Shaw introducing his nonprofit 250DAYS.ORG, emphasizing the importance of mental health awareness and recovery, thereby enhancing the program's social impact.
  • International Expansion Plans: New to The Street plans to launch its international version in the MENA region on January 24, 2026, further expanding its global reach, while also preparing to launch the Spanish-language platform Nuevo En La Calle, showcasing its diversified media strategy.
Yahoo Finance
1.0
2025-12-27Yahoo Finance
New to The Street Highlights Blockchain and Oncology Innovations in Episode #710
  • Blockchain Infrastructure Acceleration: TokenFI's Chief Revenue Officer Pedro Vidal discussed strategies for accelerating institutional adoption of blockchain tokenization, aiming to build scalable, compliance-ready infrastructure for real asset issuance, which is expected to drive transformation in financial markets.
  • New Oncology Treatment Platform: NeOnc Technologies' CEO Amir Heshmatpour introduced an intranasal drug delivery platform targeting aggressive brain cancers along with its clinical and regulatory roadmap, potentially providing new treatment options and improving survival rates for patients.
  • AI-Driven Drug Discovery: Lantern Pharma's CEO Panna Sharma outlined their AI-driven approach to oncology drug discovery, enhancing research speed and capital efficiency, which is anticipated to increase clinical success rates and expedite new drug market entry.
  • Infrastructure Investment Strategy: Mataterra Holdings' co-chairmen Monika Proffitt and Douglas Anderson provided strategic insights on global infrastructure development and real asset tokenization, emphasizing the importance of capital formation to meet future market demands.
Newsfilter
4.5
2025-12-16Newsfilter
Synergy CHC Appoints Pedro Colmenares as Sales Director for Mexico & Latin America
  • Market Expansion Strategy: Synergy CHC has appointed Pedro Colmenares as Director of Sales and Marketing for Mexico and Latin America, aiming to leverage his extensive experience to drive market expansion in the region, particularly in the supplement and functional beverage sectors.
  • New Subsidiary Formation: The company established a wholly owned subsidiary in Mexico in May 2025 and began shipments to Costco Mexico this week, marking its initial market entry and laying the groundwork for future sales growth.
  • Rich Leadership Experience: Colmenares brings over 18 years of industry experience from roles at Procter & Gamble and Victus/Megalabs, which will aid Synergy in building scalable commercial platforms and driving sustainable growth in Latin America.
  • Brand Development Potential: The success of the FOCUSfactor brand in the U.S., Canada, and the U.K. provides a strong market foundation for Synergy, and combined with Colmenares' localized execution capabilities, significant growth in the Latin American market is anticipated.
Newsfilter
7.5
2025-12-15Newsfilter
Synergy CHC Corp. Expands FOCUSfactor Distribution with New DSD Partnerships
  • Partnership Expansion: Synergy CHC Corp. has formed new Direct Store Delivery (DSD) partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., significantly enhancing its retail distribution network in Maine and Pennsylvania, which is expected to accelerate the market penetration of FOCUSfactor functional beverages.
  • Increased Market Coverage: The addition of these new partners expands Synergy's DSD network, marking continued progress in establishing a nationwide distribution footprint, which is anticipated to drive sales growth for FOCUSfactor products in the Northeast market.
  • Strengthened Brand Presence: Distributors like Pine State Beverage and Fuhrer Beverage Company bring deep market expertise and strong retail relationships, providing robust support for FOCUSfactor's expansion and ensuring best-in-class execution across key regions.
  • Future Growth Expectations: With the implementation of these new partnerships, Synergy expects to announce additional distribution partners and market expansion plans in the coming weeks, further solidifying its market position in the functional beverage sector.
Wall Street analysts forecast SNYR stock price to rise
2 Analyst Rating
Wall Street analysts forecast SNYR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Current: 0.000
sliders
Low
5.00
Averages
6.00
High
7.00
Ascendiant
Edward Woo
Buy
initiated
$5
AI Analysis
2026-02-02
Reason
Ascendiant
Edward Woo
Price Target
$5
AI Analysis
2026-02-02
initiated
Buy
Reason
Ascendiant analyst Edward Woo initiated coverage of Synergy CHC with a Buy rating and $5 price target. Synergy provides consumer health care, beauty, and lifestyle products, the analyst tells investors in a research note. The firm sees large market opportunities for the company's brain health supplement FOCUSfactor.
Roth Capital
Sean McGowan
Buy
downgrade
$10 -> $7
2025-11-14
Reason
Roth Capital
Sean McGowan
Price Target
$10 -> $7
2025-11-14
downgrade
Buy
Reason
Roth Capital analyst Sean McGowan lowered the firm's price target on Synergy CHC to $7 from $10 and keeps a Buy rating on the shares. The company made good progress during Q3, broadening its distribution footprint for both supplements and beverages and continuing to expand geographically, though its results came up short of expectations due in part to cash being tight prior to the company's recent equity raise, the analyst tells investors in a research note. Roth adds however that Synergy now has the capital needed to post significant growth in 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SNYR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Synergy CHC Corp (SNYR.O) is 0.00, compared to its 5-year average forward P/E of 0.59. For a more detailed relative valuation and DCF analysis to assess Synergy CHC Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.59
Current PE
0.00
Overvalued PE
2.66
Undervalued PE
-1.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
4.01
Current EV/EBITDA
4.01
Overvalued EV/EBITDA
6.41
Undervalued EV/EBITDA
1.61

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.43
Current PS
0.44
Overvalued PS
0.69
Undervalued PS
0.18

Financials

AI Analysis
Annual
Quarterly

Whales Holding SNYR

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Synergy CHC Corp (SNYR) stock price today?

The current price of SNYR is 1.17 USD — it has increased 3.54

What is Synergy CHC Corp (SNYR)'s business?

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

What is the price predicton of SNYR Stock?

Wall Street analysts forecast SNYR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNYR is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Synergy CHC Corp (SNYR)'s revenue for the last quarter?

Synergy CHC Corp revenue for the last quarter amounts to 8.01M USD, increased 12.40

What is Synergy CHC Corp (SNYR)'s earnings per share (EPS) for the last quarter?

Synergy CHC Corp. EPS for the last quarter amounts to 0.01 USD, decreased -90.00

How many employees does Synergy CHC Corp (SNYR). have?

Synergy CHC Corp (SNYR) has 21 emplpoyees as of March 26 2026.

What is Synergy CHC Corp (SNYR) market cap?

Today SNYR has the market capitalization of 13.16M USD.